Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Must Up Pressure To Secure Swiss Device MRA Or Transitional Arrangements

Executive Summary

Patient care and device trade will suffer without urgent attention to the signing of the EU-Switzerland medtech mutual recognition agreement, say German health care products groups.

You may also be interested in...

‘A Divorce But We Weren’t Even Married’ – Swiss Medtech Expects No EU MRA Before May

A last-minute solution to the unresolved EU MRA issue is unlikely, so local manufacturers must prepare for Switzerland to be a “third country” to the EU after the MDR comes fully into force.

Swiss Referendum Outcome A Positive Step Toward Swiss/EU Future Trade Agreement

Detailed talks are still needed between the EU and Switzerland over the future of their mutual recognition agreement. But the biggest stumbling block has been removed.

EU/Swiss MRA (mutual recognition agreement) belatedly comes into force

The mutual recognition agreement (MRA) between Switzerland and the European Union in medical devices cam into force as Clinica to press. The MRA includes products covered by the EU's Active Implantable Medical Device Directive and the Medical Devices Directive. It does not yet include products covered by the In Vitro Diagnostics Directive, although details of amendments to allow for this have been exchanged between the two parties and informally agreed upon.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts